Chemoinformaics analysis of Hexyl 4-methylpentanoate
| Molecular Weight | 200.322 | nRot | 8 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 2 |
| Exact Molecular Weight | 200.178 | nRing | 0 |
| Solubility: LogS | -1.842 | nHRing | 0 |
| Solubility: LogP | 2.351 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 37.647 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.444 |
| Synth | 2.448 |
| Natural Product Likeliness | 1.007 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.007 |
| CACO-2 | -4.343 |
| MDCK | 0.0000289 |
| BBB | 0.996 |
| PPB | 0.441546 |
| VDSS | 0.617 |
| FU | 0.757897 |
| CYP1A2-inh | 0.791 |
| CYP1A2-sub | 0.197 |
| CYP2c19-inh | 0.23 |
| CYP2c19-sub | 0.715 |
| CYP2c9-inh | 0.107 |
| CYP2c9-sub | 0.669 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.294 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.225 |
| CL | 10.701 |
| T12 | 0.876 |
| hERG | 0.004 |
| Ames | 0.005 |
| ROA | 0.047 |
| SkinSen | 0.945 |
| Carcinogencity | 0.624 |
| EI | 0.99 |
| Respiratory | 0.484 |
| NR-Aromatase | 0.019 |
| Antiviral | Yes |
| Prediction | 0.682033 |